Overview

Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

Status:
Completed

Trial end date:
2018-04-20

Target enrollment:

Participant gender:

Summary

The study aims to evaluate arterial stiffness and endothelial function indexes and their relationship with clinic and laboratory varible in a group of diabetic patients in treatment with dulaglutide

Phase:

Phase 4

Details

Lead Sponsor:

University of Palermo

Treatments:

Dulaglutide
Immunoglobulin Fc Fragments
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin Glargine
Insulin, Globin Zinc
Insulin, Long-Acting
Metformin
Repaglinide